Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Proteomic profiling identifies novel independent relationships between inflammatory proteins and myocardial infarction.

Valdes-Marquez E. et al, (2023), Eur J Prev Cardiol

Apolipoprotein Proteomics for Residual Lipid-Related Risk in Coronary Heart Disease.

Clarke R. et al, (2023), Circulation research

Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants.

Aragam KG. et al, (2022), Nature genetics, 54, 1803 - 1815

Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries.

Mishra A. et al, (2022), Nature

Stroke genetics informs drug discovery and risk prediction across ancestries.

Mishra A. et al, (2022), Nature, 611, 115 - 123

Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials.

Cholesterol Treatment Trialists' Collaboration None., (2022), Lancet (London, England), 400, 832 - 845

Oxidized phospholipids on apolipoprotein B-100 versus plasminogen and risk of coronary heart disease in the PROCARDIS study.

Clarke R. et al, (2022), Atherosclerosis, 354, 15 - 22

Multiplexed apolipoprotein profiling advances the assessment of residual lipid-related cardiovascular risk

Schmidt L. et al, (2022), CARDIOVASCULAR RESEARCH, 118

Multi-phenotype analyses of hemostatic traits with cardiovascular events reveal novel genetic associations.

Temprano-Sagrera G. et al, (2022), Journal of thrombosis and haemostasis : JTH, 20, 1331 - 1349

Are polygenic risk scores for systolic blood pressure and LDL-cholesterol associated with treatment effectiveness, and clinical outcomes among those on treatment?

Tapela NM. et al, (2022), European journal of preventive cardiology, 29, 925 - 937

Genetic associations of adult height with risk of cardioembolic and other subtypes of ischemic stroke: A mendelian randomization study in multiple ancestries.

Linden AB. et al, (2022), PLoS medicine, 19

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.

HPS3/TIMI55-REVEAL Collaborative Group None. et al, (2022), European heart journal, 43, 1416 - 1424

CHALLENGES IN EXTRAPOLATION WHEN THERE ARE MULTIPLE HEALTH OUTCOMES

Willliam C. et al, (2022), VALUE IN HEALTH, 25, S358 - S358

The impact of atrial fibrillation and stroke risk factors on left atrial blood flow characteristics.

Spartera M. et al, (2021), Eur Heart J Cardiovasc Imaging

Robust estimates of heritable coronary disease risk in individuals with type 2 diabetes.

Grace C. et al, (2021), Genet Epidemiol

Genome-Wide Association Study of Peripheral Artery Disease.

van Zuydam NR. et al, (2021), Circulation. Genomic and precision medicine

Impact of ACLY on type 2 diabetes in UK Biobank: a Mendelian randomisation study

Stiby A. et al, (2021), EUROPEAN HEART JOURNAL, 42, 3011 - 3011

Impact of adverse events on quality of life and hospital costs in secondary cardiovascular disease prevention

Lui NMJ. et al, (2021), EUROPEAN HEART JOURNAL, 42, 3159 - 3159

Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort.

Clift AK. et al, (2021), Thorax

Independent effects of adiposity measures on risk of atrial fibrillation in men and women: A study of 0.5M individuals

CAMM C. et al, (2021), International Journal of Epidemiology

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?